UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck Cancer
UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck CancerKey Takeaways:- USCD and Cofactor partner to improve physician's ability to predict tumor response.
- Ezra Cohen, MD, Chief of the Division of Hematology‐Oncology at the UCSD Moores Cancer Center is the Primary Investigator for the collaboration.
- The study will leverage Cofactor's Predictive Immune Modeling platform to analyze clinical specimens and outcomes data well-curated by UCSD.
Click image above to view full announcement.
About Cofactor Genomics
Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right treatment at the right time. Predicting patient response to therapy currently relies on isolated, single-analyte biomarkers that have failed to deliver accurate therapy response predictions, resulting in unnecessary healthcare costs, and most harmfully, negative outcomes for patients. Cofactor's products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful. Find out more about how Cofactor Genomics is revolutionizing precision medicine at cofactorgenomics.com.
About UCSD
UC San Diego Health, comprising a comprehensive health system throughout San Diego County, UC San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, is one of five academic medical systems within the University of California system. We are committed to improving patient care while also researching new treatments and training tomorrow's doctors and pharmacists. For more than 50 years, our renowned clinicians and scientists have made advances in numerous fields, including minimally invasive surgeries, personalized cancer therapy, cardiovascular treatment and surgery, transplantation and the early detection of autism. Our specialty patient care is consistently ranked among the nation's best by U.S. News & World Report.
Contacts:
Mariesa Kemble, Chronic Communications Inc.
(608) 850-4745
Scott LaFee
(858) 249-0456
Heather Buschman, PhD
(858) 249-0456
Source: Cofactor Genomics
Distributed by: Reportable, Inc.